Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss 2014 Financial Results and Provide Corporate Update

March 09, 2015 – Xenon Pharmaceuticals Inc.

BURNABY, British Columbia – March 9, 2015 – Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its 2014 financial and operating results after the close of U.S. financial markets on Thursday, March 12, 2015. Xenon management will host a conference call and live audio webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) the same day to discuss those results and to provide a corporate update.

The live call may be accessed by dialing (855) 779-9075 for domestic callers or (631) 485-4866 for international callers, and providing conference ID number 2233926. The webcast will be broadcast live on the investors section of Xenon’s website at www.xenon-pharma.com and will be available for replay following the call for 30 days.

Ian Mortimer
Chief Financial Officer
Xenon Pharmaceuticals Inc.
Phone: 604.484.3300
Email: investors@xenon-pharma.com